Literature DB >> 1398930

Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile.

S P Borriello1, B W Wren, S Hyde, S V Seddon, P Sibbons, M M Krishna, S Tabaqchali, S Manek, A B Price.   

Abstract

A cytotoxigenic Clostridium difficile strain that fails to produce toxin A but causes hemorrhage and bloody fluid accumulation in ligated ileal loops of rabbits and hemorrhage and diarrhea in hamsters is described. The lack of reaction of DNA from this strain in hybridization studies with a toxin A gene-specific 4.5-kb probe and polymerase chain reaction studies with six toxin A-specific primers indicate the absence of the toxin A gene. The cytotoxin produced by this strain was not responsible for the enterotoxic or hemorrhagic activity and shared characteristics with toxin B, i.e., its cytotoxicity was neutralized by antibodies to toxigenic strains of C. difficile and Clostridium sordellii. Polymerase chain reaction studies with toxin B-specific primers showed that the DNA from this strain produced a 690-bp product in addition to the expected 591-bp product.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1398930      PMCID: PMC257452          DOI: 10.1128/iai.60.10.4192-4199.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon.

Authors:  T J Mitchell; J M Ketley; S C Haslam; J Stephen; D W Burdon; D C Candy; R Daniel
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

2.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

3.  Separation of two cytotoxins of Clostridium sordellii strains.

Authors:  K Yamakawa; S Nakamura; S Nishida
Journal:  Microbiol Immunol       Date:  1985       Impact factor: 1.955

4.  Simplified procedure for the routine isolation of Clostridium difficile from faeces.

Authors:  S P Borriello; P Honour
Journal:  J Clin Pathol       Date:  1981-10       Impact factor: 3.411

5.  Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile.

Authors:  Y Banno; T Kobayashi; H Kono; K Watanabe; K Ueno; Y Nozawa
Journal:  Rev Infect Dis       Date:  1984 Mar-Apr

6.  Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis.

Authors:  S P Borriello; J M Ketley; T J Mitchell; F E Barclay; A R Welch; A B Price; J Stephen
Journal:  J Med Microbiol       Date:  1987-08       Impact factor: 2.472

7.  Typing scheme for Clostridium difficile: its application in clinical and epidemiological studies.

Authors:  S Tabaqchali; D Holland; S O'Farrell; R Silman
Journal:  Lancet       Date:  1984-04-28       Impact factor: 79.321

8.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

9.  An in-vitro model of colonisation resistance to Clostridium difficile infection.

Authors:  S P Borriello; F E Barclay
Journal:  J Med Microbiol       Date:  1986-06       Impact factor: 2.472

10.  Effects of Clostridium difficile toxins given intragastrically to animals.

Authors:  D M Lyerly; K E Saum; D K MacDonald; T D Wilkins
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

View more
  35 in total

Review 1.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease.

Authors:  S P Sambol; M M Merrigan; D Lyerly; D N Gerding; S Johnson
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Clostridium difficile infection of the gut.

Authors:  A P Dodson; S P Borriello
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

4.  Positive regulation of Clostridium difficile toxins.

Authors:  J S Moncrief; L A Barroso; T D Wilkins
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

Review 5.  An Update on Clostridium difficile Toxinotyping.

Authors:  Maja Rupnik; Sandra Janezic
Journal:  J Clin Microbiol       Date:  2015-10-28       Impact factor: 5.948

6.  International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants.

Authors:  Stuart Johnson; Susan P Sambol; Jon S Brazier; Michel Delmée; V Avesani; Michelle M Merrigan; Dale N Gerding
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

7.  Premarket evaluations of the IMDx C. difficile for Abbott m2000 Assay and the BD Max Cdiff Assay.

Authors:  K A Stellrecht; A A Espino; V P Maceira; S M Nattanmai; S A Butt; D Wroblewski; G E Hannett; K A Musser
Journal:  J Clin Microbiol       Date:  2014-02-19       Impact factor: 5.948

8.  Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates.

Authors:  Patrizia Spigaglia; Paola Mastrantonio
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

9.  High frequency of antibiotic-associated diarrhea due to toxin A-negative, toxin B-positive Clostridium difficile in a hospital in Japan and risk factors for infection.

Authors:  M Komatsu; H Kato; M Aihara; K Shimakawa; M Iwasaki; Y Nagasaka; S Fukuda; S Matsuo; Y Arakawa; M Watanabe; Y Iwatani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-21       Impact factor: 3.267

10.  Relapses or reinfections: analysis of a case of Clostridium difficile-associated colitis by two typing systems.

Authors:  H Kato; N Kato; K Watanabe; K Ueno; Y Sakata; K Fujita
Journal:  Curr Microbiol       Date:  1996-10       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.